Favipiravir Bioanalysis [Regulatives / Guidelines]

posted by Ayman Rabayah – Jordan, 2020-08-11 10:44 (898 d 14:19 ago) – Posting: # 21854
Views: 1,457

Hellow colleagues
Need your feedback about the Bio-analysis of Favipiravir, do the metabolite (Favipiravir RTP) need to be measured or only the Favipiravir, since no FDA or EMEA related guidance issued till date.
Appreciate your thoughts.

Ayman Ahmad

Complete thread:

UA Flag
Activity
 Admin contact
22,477 posts in 4,708 threads, 1,603 registered users;
21 visitors (0 registered, 21 guests [including 9 identified bots]).
Forum time: 00:03 CET (Europe/Vienna)

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5